Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023 Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …
News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023 Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …
News

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023 Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …
News

First Wave BioPharma announces phase 2 trial

January 31, 2023 Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …
News

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023 Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …
News

IsoChemiX develop molecules to speed up R&D process

January 27, 2023 Research and Development

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …
News

AI finds liver cancer drug candidate in only 30 days

January 26, 2023 Research and Development

With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …
News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023 Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023 Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …
News

FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment

January 23, 2023 Research and Development

Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …
News

AI and motion capture technology used to monitor movement disorders

January 23, 2023 Research and Development

A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …
News

FDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug, donanemab

January 20, 2023 Research and Development

Eli Lilly has announced that its accelerated approval bid for Alzheimer’s disease drug, donanemab, has been rejected by the FDA. …
News

Genentech announce positive results from phase 3 IMbrave050 study

January 19, 2023 Research and Development

Genentech, based in California, US, has announced positive results from its phase 3 IMbrave050 trial, after the study met its …
News

Moderna’s mRNA vaccine appears promising for older adults with RSV

January 19, 2023 Research and Development

Moderna’s respiratory syncytial virus (RSV) vaccine has demonstrated positive levels of efficacy in older adults throughout a phase 3 trial. …
News

Neuronetics Inc. announces efficacy of treatment for neurohealth disorders

January 18, 2023 Research and Development

US-based commercial-stage medical technology company Neuronetics Inc., which focuses on designing, developing and marketing products that improve the quality of …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026